A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection.
- 26 April 1994
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 91 (9) , 3657-3661
- https://doi.org/10.1073/pnas.91.9.3657
Abstract
One strategy for somatic gene therapy for human immunodeficiency virus type 1 (HIV-1) infection is based on the regulated expression of dominant negative mutants of the HIV-1 gag gene. To limit expression of the mutant Gag polypeptide to HIV-1-infected cells, we have constructed a replication-defective retroviral vector that contains a Rev-responsive element. By using this construct we have obviated problems that can be associated with constitutive expression of an exogenous gene, an important step toward developing a human therapy. In uncloned T lymphocytes infected (transduced) with this retroviral construct, HIV-1 replication was inhibited by 94% with a concomitant decrease in the cytopathic effects of the virus. In addition, simian immunodeficiency virus (SIV) replication was also shown to be significantly inhibited, suggesting that this mutant Gag protein may have antiviral efficacy against a broad range of primate lentiviruses and that an SIV/macaque model can be used for further in vivo studies. These results have important implications in assessing the potential of somatic gene therapy in the treatment of HIV-1 infection.Keywords
This publication has 30 references indexed in Scilit:
- HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: Implications for HIV-1 latencyCell, 1991
- An in Vivo Model of Somatic Cell Gene Therapy for Human Severe Combined ImmunodeficiencyScience, 1991
- Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.1991
- Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replicationCell, 1990
- Trans-activating rev protein of the human immunodeficiency virus 1 interacts directly and specifically with its target RNA.Proceedings of the National Academy of Sciences, 1990
- HIV-1 structural gene expression requires binding of the rev trans-activator to its RNA target sequenceCell, 1990
- Sequence-specific RNA binding by the HIV-1 Rev proteinNature, 1989
- IMPROVED RETROVIRAL VECTORS FOR GENE-TRANSFER AND EXPRESSION1989
- Mutational analysis of HIV-1 Tat minimal domain peptides: Identification of trans-dominant mutants that suppress HIV-LTR-driven gene expressionCell, 1989
- Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev functionCell, 1989